Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

@article{Hamaguchi2007NonalcoholicFL,
  title={Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.},
  author={Masahide Hamaguchi and Takao Kojima and Noriyuki Takeda and Chisato Nagata and Jun Takeda and Hiroshi Sarui and Yutaka Kawahito and Naohisa Yoshida and Atsushi Suetsugu and Takahiro A. Kato and Junichi Okuda and Kazunori Ida and Toshikazu Yoshikawa},
  journal={World journal of gastroenterology},
  year={2007},
  volume={13 10},
  pages={
          1579-84
        }
}
AIM To clarify whether nonalcoholic fatty liver disease (NAFLD) increases the risk of cardiovascular disease. METHODS We carried out a prospective observational study with a total of 1637 apparently healthy Japanese men and women who were recruited from a health check-up program. NAFLD was diagnosed by abdominal ultrasonography. The metabolic syndrome (MS) was defined according to the modified National Cholesterol Education Program (NCEP) ATP III criteria. Five years after the baseline… Expand
Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events.
TLDR
NAFLD is a good predictor of cardiovascular and renal diseases, and Logistic regression analysis revealed that NAFLD was the best predictor for cardiovascular and kidneys impairment. Expand
Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
  • M. Stepanova, Z. Younossi
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2012
TLDR
NAFLD was associated independently with CVD, after adjusting for major demographic, clinical, and metabolic confounders, and did not increase cardiovascular mortality over a 14-year period. Expand
Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease
TLDR
Nonoverweight with NAFLD was associated with higher risk of incident CVD, and should be paid attention to, even in nonoverweight individuals, to prevent further CVD events. Expand
Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events
  • Jie Xu, Liye Dai, +6 authors Yongjun Wang
  • Medicine
  • Stroke
  • 2020
TLDR
The severity of NAFLD is associated with a higher risk of future ischemic stroke events, and this work has shown that nonalcoholic fatty liver disease and its severity predict future IS events in a community-based cohort. Expand
Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients
TLDR
NAFLD was strongly associated with CAS and the correlation between NAFLD and significant coronary stenosis appeared to be stronger in women than in men, but the absolute risk was higher in men than in women. Expand
Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease.
TLDR
AlT was a predictor of prevalent CHD in men but not in women, while CT measured FL was not significant in either sex, suggesting the failure to account for traditional risk factors, heterogeneity by sex, and varying definitions of NAFLD may account for some of the conflicting evidence. Expand
Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
TLDR
NAFLD is likely to be associated with an increased risk of CVD, and raises the possibility that NAFLD may not only be a marker but also an early mediator ofCVD. Expand
Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke
TLDR
NAFLD-fibrosis may be associated with stroke in addition to heart disease, with differences depending on the measure used to define NAFLS, as well as with demographic variables and cardiovascular risk factors. Expand
Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women
TLDR
There is a significant correlation between NAFLD and prevalence of CAC, butNAFLD is not an independent factor for coronary atherosclerosis in postmenopausal women. Expand
Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.
TLDR
In a large, multi-ethnic, gender balanced cohort, CT-diagnosed nonalcoholic fatty liver disease was associated with the atherogenic dyslipidemia phenotype in a dose dependent fashion, suggesting a possible independent pathophysiologic role between NAFLD and dys Lipoprotein abnormalities. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.
TLDR
In conclusion, NAFLD is significantly associated with a moderately increased CVD risk among type 2 diabetic individuals and is independent of classical risk factors and is only partly explained by occurrence of metabolic syndrome. Expand
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study
TLDR
Patients with NAFLD show a cluster of risk factors of the metabolic syndrome and advanced carotid atherosclerosis, and its detection on abdominal ultrasound should alert to the existence of an increased cardiovascular risk. Expand
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
TLDR
Evaluated the cross-sectional relationship between the metabolic syndrome, defined by the modified ATP III criteria, and the prevalence of nonalcoholic fatty liver disease in Japanese persons and addressed longitudinal aspects of the disease and its development and regression. Expand
Hepatic steatosis and vascular disease.
TLDR
There is emerging evidence suggesting that there is a significant increase in vascular oxidative stress in patients with MS, with the presence of endothelial dysfunction in the early stage of the syndrome. Expand
Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics.
TLDR
The aim of this work is to determine the prevalence of nonalcoholic fatty liver disease in the general population in Saudi Arabia and to describe its impact on racial groups. Expand
Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease.
TLDR
Specific relationships between hepatic histology and markers of the metabolic syndrome are explored in human subjects with nonalcoholic fatty liver disease, finding that insulin resistance, even without these other features, is almost universal in subjects with NAFLD. Expand
Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients
TLDR
It is suggested that among diet-controlled Type 2 diabetic individuals the significant increase of carotid IMT in the presence of NAFLD is largely explained by HOMA-estimated insulin resistance. Expand
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
TLDR
Cardiovascular disease and all-cause mortality are increased in men with the metabolic syndrome, even in the absence of baseline CVD and diabetes, according to the Kuopio Ischaemic Heart Disease Risk Factor Study. Expand
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
TLDR
Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver disease in the United States, and steatosis alone has a more benign clinical course, although progression to cirrhosis has occurred in 3% of these patients. Expand
Fatty Infiltration of Liver in Hyperlipidemic Patients
TLDR
It is indicated that ultrasonographic evidence of fatty infiltration of the liver is evident in approximately 50% of patients with hyperlipidemia, and diabetes was the only risk factor other than hypertriglyceridemia that was significantly associated with fatty infiltration. Expand
...
1
2
3
...